David MacHin

David Machin, Children’s Cancer and Leukaemia Group, University of Leicester, UK; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore; Medical Statistics Unit, School of Health and Related Sciences, University of Sheffield, UK Michael J. Campbell, Medical Statistics Unit, School of Health and Related Sciences, University of Sheffield, UK Say Beng Tan, Singapore Clinical Research Institute, Singapore; Duke–NUS Graduate Medical School, Singapore Sze Huey Tan, Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore